NCT00614380
Open Label Study Telmisartan and Amlodipine in Hypertension
See it on ClinicalTrials.gov ↗976 people
37.4%
62.6%
365 womenmiddle line = equal numbers611 men
- Phase
- PHASE3
- Paid for by
- Boehringer Ingelheim
- Finished
- —
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 53.9 Years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“pre-menopausal women who are not surgically sterile; or are nursing or pregnant; or are not practising acceptable means of birth control or do not plan to continue using acceptable means of birth control throughout the study”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“pre-menopausal women who are not surgically sterile; or are nursing or pregnant; or are not practising acceptable means of birth control or do not plan to continue using acceptable means of birth control throughout the study”
Study titles and rules are shown in their original English.